LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000150

Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial

Identifieur interne : 000150 ( PascalFrancis/Corpus ); précédent : 000149; suivant : 000151

Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial

Auteurs : Sandra C. Hayes ; Rebecca M. Speck ; Elizabeth Reimet ; Azadeh Stark ; Kathryn H. Schmitz

Source :

Breast cancer research and treatment [ 0167-6806 ] ; 2011.

RBID : Pascal:11-0457881

Descripteurs français

Pascal (Inist)
- Poids, Lymphoedème, Cancer du sein, Diagnostic, Méthode, Résistance mécanique, Essai randomisé contrôlé.

English descriptors

KwdEn :
- Breast cancer, Diagnosis, Lymphedema, Method, Randomized controlled trial, Strength, Weight.

Abstract

The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0167-6806`
A02	`01`			`@0 BCTRD6`
A03		`1`		`@0 Breast cancer res. treat.`
A05				`@2 130`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial`
A11	`01`	`1`		`@1 HAYES (Sandra C.)`
A11	`02`	`1`		`@1 SPECK (Rebecca M.)`
A11	`03`	`1`		`@1 REIMET (Elizabeth)`
A11	`04`	`1`		`@1 STARK (Azadeh)`
A11	`05`	`1`		`@1 SCHMITZ (Kathryn H.)`
A14	`01`			`@1 Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation @2 Brisbane @3 AUS @Z 1 aut.`
A14	`02`			`@1 Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall @2 19104-6021 Philadelphia, PA @3 USA @Z 2 aut. @Z 4 aut.`
A14	`03`			`@1 Department of Anesthesiology and Critical Care, University of Pennsylvania @2 Philadelphia, PA @3 USA @Z 2 aut.`
A14	`04`			`@1 Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania @2 Philadelphia @3 USA @Z 3 aut.`
A14	`05`			`@1 Center for Health Research, Geisinger Health System @2 Danville, PA @3 USA @Z 4 aut.`
A14	`06`			`@1 Department of Pathology, Henry Ford Health System @2 Detroit @3 USA @Z 4 aut.`
A14	`07`			`@1 Department of Family Medicine and Community Health, University of Pennsylvania @2 Philadelphia, PA @3 USA @Z 5 aut.`
A20				`@1 227-234`
A21				`@1 2011`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20699 @5 354000509195060230`
A44				`@0 0000 @1 © 2011 INIST-CNRS. All rights reserved.`
A45				`@0 25 ref.`
A47	`01`	`1`		`@0 11-0457881`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Breast cancer research and treatment`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.
C02	`01`	`X`		`@0 002B20E02`
C02	`02`	`X`		`@0 002B12B04`
C03	`01`	`X`	`FRE`	`@0 Poids @5 01`
C03	`01`	`X`	`ENG`	`@0 Weight @5 01`
C03	`01`	`X`	`SPA`	`@0 Peso @5 01`
C03	`02`	`X`	`FRE`	`@0 Lymphoedème @5 02`
C03	`02`	`X`	`ENG`	`@0 Lymphedema @5 02`
C03	`02`	`X`	`SPA`	`@0 Linfedema @5 02`
C03	`03`	`X`	`FRE`	`@0 Cancer du sein @2 NM @5 03`
C03	`03`	`X`	`ENG`	`@0 Breast cancer @2 NM @5 03`
C03	`03`	`X`	`SPA`	`@0 Cáncer del pecho @2 NM @5 03`
C03	`04`	`X`	`FRE`	`@0 Diagnostic @5 04`
C03	`04`	`X`	`ENG`	`@0 Diagnosis @5 04`
C03	`04`	`X`	`SPA`	`@0 Diagnóstico @5 04`
C03	`05`	`X`	`FRE`	`@0 Méthode @5 05`
C03	`05`	`X`	`ENG`	`@0 Method @5 05`
C03	`05`	`X`	`SPA`	`@0 Método @5 05`
C03	`06`	`X`	`FRE`	`@0 Résistance mécanique @5 06`
C03	`06`	`X`	`ENG`	`@0 Strength @5 06`
C03	`06`	`X`	`SPA`	`@0 Resistencia mecánica @5 06`
C03	`07`	`X`	`FRE`	`@0 Essai randomisé contrôlé @4 CD @5 96`
C03	`07`	`X`	`ENG`	`@0 Randomized controlled trial @4 CD @5 96`
C03	`07`	`X`	`SPA`	`@0 Ensayo aleatorio controlado @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'appareil circulatoire @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Pathologie des vaisseaux lymphatiques @5 38`
C07	`02`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Linfático patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Tumeur maligne @2 NM @5 39`
C07	`03`	`X`	`ENG`	`@0 Malignant tumor @2 NM @5 39`
C07	`03`	`X`	`SPA`	`@0 Tumor maligno @2 NM @5 39`
C07	`04`	`X`	`FRE`	`@0 Cancer @2 NM`
C07	`04`	`X`	`ENG`	`@0 Cancer @2 NM`
C07	`04`	`X`	`SPA`	`@0 Cáncer @2 NM`
C07	`05`	`X`	`FRE`	`@0 Pathologie de la glande mammaire @2 NM @5 40`
C07	`05`	`X`	`ENG`	`@0 Mammary gland diseases @2 NM @5 40`
C07	`05`	`X`	`SPA`	`@0 Glándula mamaria patología @2 NM @5 40`
C07	`06`	`X`	`FRE`	`@0 Pathologie du sein @2 NM @5 41`
C07	`06`	`X`	`ENG`	`@0 Breast disease @2 NM @5 41`
C07	`06`	`X`	`SPA`	`@0 Seno patología @2 NM @5 41`
N21				`@1 311`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 11-0457881 INIST
ET :	Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial
AU :	HAYES (Sandra C.); SPECK (Rebecca M.); REIMET (Elizabeth); STARK (Azadeh); SCHMITZ (Kathryn H.)
AF :	Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation/Brisbane/Australie (1 aut.); Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall/19104-6021 Philadelphia, PA/Etats-Unis (2 aut., 4 aut.); Department of Anesthesiology and Critical Care, University of Pennsylvania/Philadelphia, PA/Etats-Unis (2 aut.); Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania/Philadelphia/Etats-Unis (3 aut.); Center for Health Research, Geisinger Health System/Danville, PA/Etats-Unis (4 aut.); Department of Pathology, Henry Ford Health System/Detroit/Etats-Unis (4 aut.); Department of Family Medicine and Community Health, University of Pennsylvania/Philadelphia, PA/Etats-Unis (5 aut.)
DT :	Publication en série; Niveau analytique
SO :	Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2011; Vol. 130; No. 1; Pp. 227-234; Bibl. 25 ref.
LA :	Anglais
EA :	The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.
CC :	002B20E02; 002B12B04
FD :	Poids; Lymphoedème; Cancer du sein; Diagnostic; Méthode; Résistance mécanique; Essai randomisé contrôlé
FG :	Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein
ED :	Weight; Lymphedema; Breast cancer; Diagnosis; Method; Strength; Randomized controlled trial
EG :	Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease
SD :	Peso; Linfedema; Cáncer del pecho; Diagnóstico; Método; Resistencia mecánica; Ensayo aleatorio controlado
LO :	INIST-20699.354000509195060230
ID :	11-0457881

Links to Exploration step

Pascal:11-0457881

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial</title>
<author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C." last="Hayes">Sandra C. Hayes</name>
<affiliation><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation</s1>
<s2>Brisbane</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Speck, Rebecca M" sort="Speck, Rebecca M" uniqKey="Speck R" first="Rebecca M." last="Speck">Rebecca M. Speck</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall</s1>
<s2>19104-6021 Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Anesthesiology and Critical Care, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reimet, Elizabeth" sort="Reimet, Elizabeth" uniqKey="Reimet E" first="Elizabeth" last="Reimet">Elizabeth Reimet</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania</s1>
<s2>Philadelphia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stark, Azadeh" sort="Stark, Azadeh" uniqKey="Stark A" first="Azadeh" last="Stark">Azadeh Stark</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall</s1>
<s2>19104-6021 Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Center for Health Research, Geisinger Health System</s1>
<s2>Danville, PA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Pathology, Henry Ford Health System</s1>
<s2>Detroit</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Family Medicine and Community Health, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0457881</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0457881 INIST</idno>
<idno type="RBID">Pascal:11-0457881</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000150</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial</title>
<author><name sortKey="Hayes, Sandra C" sort="Hayes, Sandra C" uniqKey="Hayes S" first="Sandra C." last="Hayes">Sandra C. Hayes</name>
<affiliation><inist:fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation</s1>
<s2>Brisbane</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Speck, Rebecca M" sort="Speck, Rebecca M" uniqKey="Speck R" first="Rebecca M." last="Speck">Rebecca M. Speck</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall</s1>
<s2>19104-6021 Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="03"><s1>Department of Anesthesiology and Critical Care, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Reimet, Elizabeth" sort="Reimet, Elizabeth" uniqKey="Reimet E" first="Elizabeth" last="Reimet">Elizabeth Reimet</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania</s1>
<s2>Philadelphia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stark, Azadeh" sort="Stark, Azadeh" uniqKey="Stark A" first="Azadeh" last="Stark">Azadeh Stark</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall</s1>
<s2>19104-6021 Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="05"><s1>Center for Health Research, Geisinger Health System</s1>
<s2>Danville, PA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="06"><s1>Department of Pathology, Henry Ford Health System</s1>
<s2>Detroit</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Family Medicine and Community Health, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast cancer</term>
<term>Diagnosis</term>
<term>Lymphedema</term>
<term>Method</term>
<term>Randomized controlled trial</term>
<term>Strength</term>
<term>Weight</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Poids</term>
<term>Lymphoedème</term>
<term>Cancer du sein</term>
<term>Diagnostic</term>
<term>Méthode</term>
<term>Résistance mécanique</term>
<term>Essai randomisé contrôlé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-6806</s0>
</fA01>
<fA02 i1="01"><s0>BCTRD6</s0>
</fA02>
<fA03 i2="1"><s0>Breast cancer res. treat.</s0>
</fA03>
<fA05><s2>130</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>HAYES (Sandra C.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SPECK (Rebecca M.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>REIMET (Elizabeth)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>STARK (Azadeh)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SCHMITZ (Kathryn H.)</s1>
</fA11>
<fA14 i1="01"><s1>Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation</s1>
<s2>Brisbane</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall</s1>
<s2>19104-6021 Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Anesthesiology and Critical Care, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania</s1>
<s2>Philadelphia</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Center for Health Research, Geisinger Health System</s1>
<s2>Danville, PA</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department of Pathology, Henry Ford Health System</s1>
<s2>Detroit</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Family Medicine and Community Health, University of Pennsylvania</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>227-234</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20699</s2>
<s5>354000509195060230</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0457881</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Poids</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Weight</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Peso</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Diagnostic</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Diagnosis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Diagnóstico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Méthode</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Method</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Método</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Résistance mécanique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Strength</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Resistencia mecánica</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Essai randomisé contrôlé</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Randomized controlled trial</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Ensayo aleatorio controlado</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fN21><s1>311</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0457881 INIST</NO>
<ET>Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial</ET>
<AU>HAYES (Sandra C.); SPECK (Rebecca M.); REIMET (Elizabeth); STARK (Azadeh); SCHMITZ (Kathryn H.)</AU>
<AF>Queensland University of Technology, School of Public Health, Institute of Biomedical Innovation/Brisbane/Australie (1 aut.); Department of Biostatistics and Epidemiology, University of Pennsylvania, 423 Guardian Drive, 903 Blockley Hall/19104-6021 Philadelphia, PA/Etats-Unis (2 aut., 4 aut.); Department of Anesthesiology and Critical Care, University of Pennsylvania/Philadelphia, PA/Etats-Unis (2 aut.); Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pennsylvania/Philadelphia/Etats-Unis (3 aut.); Center for Health Research, Geisinger Health System/Danville, PA/Etats-Unis (4 aut.); Department of Pathology, Henry Ford Health System/Detroit/Etats-Unis (4 aut.); Department of Family Medicine and Community Health, University of Pennsylvania/Philadelphia, PA/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Breast cancer research and treatment; ISSN 0167-6806; Coden BCTRD6; Pays-Bas; Da. 2011; Vol. 130; No. 1; Pp. 227-234; Bibl. 25 ref.</SO>
<LA>Anglais</LA>
<EA>The lymphedema diagnostic method used in descriptive or intervention studies may influence results found. The purposes of this work were to compare baseline lymphedema prevalence in the physical activity and lymphedema (PAL) trial cohort and to subsequently compare the effect of the weight-lifting intervention on lymphedema, according to four standard diagnostic methods. The PAL trial was a randomized controlled intervention study, involving 295 women who had previously been treated for breast cancer, and evaluated the effect of 12 months of weight lifting on lymphedema status. Four diagnostic methods were used to evaluate lymphedema outcomes: (i) interlimb volume difference through water displacement, (ii) interlimb size difference through sum of arm circumferences, (iii) interlimb impedance ratio using bioimpedance spectroscopy, and (iv) a validated self-report survey. Of the 295 women who participated in the PAL trial, between 22 and 52% were considered to have lymphedema at baseline according to the four diagnostic criteria used. No between-group differences were noted in the proportion of women who had a change in interlimb volume, interlimb size, interlimb ratio, or survey score of ≥5, ≥5, ≥10%, and 1 unit, respectively (cumulative incidence ratio at study end for each measure ranged between 0.6 and 0.8, with confidence intervals spanning 1.0). The variation in proportions of women within the PAL trial considered to have lymphoedema at baseline highlights the potential impact of the diagnostic criteria on population surveillance regarding prevalence of this common morbidity of treatment. Importantly though, progressive weight lifting was shown to be safe for women following breast cancer, even for those at risk or with lymphedema, irrespective of the diagnostic criteria used.</EA>
<CC>002B20E02; 002B12B04</CC>
<FD>Poids; Lymphoedème; Cancer du sein; Diagnostic; Méthode; Résistance mécanique; Essai randomisé contrôlé</FD>
<FG>Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques; Tumeur maligne; Cancer; Pathologie de la glande mammaire; Pathologie du sein</FG>
<ED>Weight; Lymphedema; Breast cancer; Diagnosis; Method; Strength; Randomized controlled trial</ED>
<EG>Cardiovascular disease; Lymphatic vessel disease; Malignant tumor; Cancer; Mammary gland diseases; Breast disease</EG>
<SD>Peso; Linfedema; Cáncer del pecho; Diagnóstico; Método; Resistencia mecánica; Ensayo aleatorio controlado</SD>
<LO>INIST-20699.354000509195060230</LO>
<ID>11-0457881</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000150 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000150 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0457881
   |texte=   Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial

Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri